ANCA-Associated Vasculitis: An Update for Internists

Credit Unavailable

This activity has been archived and credit is no longer available.

This Annual Finger Lecture is presented by the Department of Medicine Grand Rounds Series. Guest lecturer Dr. Peter Merkel discusses antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and its clinical manifestations, diagnostic and clinical evaluation, standard of care treatment, and experimental treatment studies.

This lecture took place on Thursday, May 13, 2021 at 12:15 P.M.

Activity Information

This activity has been archived and credit is no longer available.

Needs Statement

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Educational Objectives

At the conclusion of this activity, the participant should be able to:

  • Develop a methodology for clinically evaluating patients with ANCA-associated vasculitis (i.e., granulomatosis with polyangiitis and microscopic polyangiitis).
  • Apply the current standard-of-care treatment protocols for patients with ANCA-associated vasculitis.
  • Review the findings and implications of recent clinical trials for small vessel vasculitis.
  • Discuss the current areas of clinical investigation of ANCA-associated vasculitis.

Target Audience

Professional Categories

  • Physicians
  • Medical Students
  • Fellows
  • Residents

Specialties

  • Internal Medicine

Interest Groups

  • Hospital Medicine

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Director

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

Term of Approval

May 1, 2021 through May 31, 2023. Original release date: May 1, 2021

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Peter Merkel, M.D., M.P.H.

    Peter Merkel, M.D., M.P.H.

    Professor of Medicine and Epidemiology, Chief of Rheumatology
    Perelman School of Medicine, University of Pennsylvania

    Disclosure:
    • Research Support: AbbVie; AstraZeneca; Boeringher-Ingelheim; Bristol-Myers Squibb; Chemo Centryx; Eicos; Forbius; Genentech/Roche; Genzyme/SanofI; GlaxoSmithKline; InflaRx; Sanofi
    • Consultancy: AbbVie; AstraZeneca; Boeringher-Ingelheim; Bristol-Myers Squibb; ChemoCentryx; CSL Behring; Dynacure; EMDSerono; Forbius; Genentech/Roche; Genzyme/SanofI; GlaxoSmithKline; InflaRx; Jannsen; Kiniksa; Kyverna; Magenta; MiroBio; Neutrolis; Novartis; Pfizer; Sparrow; Takeda; Talaris

Activity Director

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Richard J. Hamill, M.D.

    Richard J. Hamill, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Erica Lescinskas, M.D.

    Erica Lescinskas, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Zaven Sargsayan, M.D.

    Zaven Sargsayan, M.D.

    Assistant Professor
    Baylor College of Medicine and Ben Taub Hospital

    Disclosure:

    Nothing to disclose.

  4. Chirayu Shah, M.D., M.Ed.

    Chirayu Shah, M.D., M.Ed.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Stephanie Sherman, M.D.

    Stephanie Sherman, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  6. Jefferson Triozzi, M.D. Placeholder Image

    Jefferson Triozzi, M.D.

    Internal Medicine Resident
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenter:

Peter Merkel, M.D., M.P.H.

Peter Merkel, M.D., M.P.H.

Professor of Medicine and Epidemiology, Chief of Rheumatology Perelman School of Medicine, University of Pennsylvania

Health Topics

You May Also Be Interested In

On Demand
Department of Medicine Grand Rounds
Activity duration: 1 hr
Activity Available On Demand
Credit No credit is available for this activity
On Demand
Department of Medicine Grand Rounds
Activity duration: 1 hr
Activity Available On Demand
Credit No credit is available for this activity
On Demand
Department of Medicine Grand Rounds
Activity duration: 1 hr
Activity Available On Demand
Credit 1.25 Continuing Medical Education Credits Available